Cross Country Healthcare to Discuss Q3 2024 Results

Cross Country Healthcare, Inc. (Nasdaq: CCRN) has announced that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024, at 5:00 p.m. Eastern Time.

The company intends to distribute its earnings press release after the market close on the same day. The call will be webcast live and can be accessed at the company’s website or by dialing specific numbers provided in the press release.

Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience. The company aims to help clients tackle complex labor-related challenges and achieve high-quality outcomes while reducing complexity and improving visibility through data-driven insights.

The upcoming call will provide investors and stakeholders with a comprehensive overview of the company's performance in the third quarter of 2024. It will be an opportunity to analyze the financial metrics and assess the company's progress.

Investors and stockholders will be keen to hear about any changes in key metrics such as revenue, earnings per share, and operating income compared to the previous period. Additionally, they will be looking for insights into the company's future outlook and strategic initiatives.

As the scheduled date approaches, the market will be eagerly awaiting the release of Cross Country Healthcare's third quarter financial results to gain valuable insights into the company's financial performance and trajectory. The market has reacted to these announcements by moving the company's shares -2.9% to a price of $12.87. For the full picture, make sure to review Cross Country Healthcare's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS